Global Neurodegenerative Disease Treatment Drug Supply, Demand and Key Producers, 2023-2029
The global Neurodegenerative Disease Treatment Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Neurodegenerative Disease Treatment Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neurodegenerative Disease Treatment Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neurodegenerative Disease Treatment Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neurodegenerative Disease Treatment Drug total market, 2018-2029, (USD Million)
Global Neurodegenerative Disease Treatment Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Neurodegenerative Disease Treatment Drug total market, key domestic companies and share, (USD Million)
Global Neurodegenerative Disease Treatment Drug revenue by player and market share 2018-2023, (USD Million)
Global Neurodegenerative Disease Treatment Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Neurodegenerative Disease Treatment Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Neurodegenerative Disease Treatment Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbvie Inc., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International Gmbh, Hoffmann-La Roche and Merck & Co. Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neurodegenerative Disease Treatment Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Neurodegenerative Disease Treatment Drug Market, By Region:
1. How big is the global Neurodegenerative Disease Treatment Drug market?
2. What is the demand of the global Neurodegenerative Disease Treatment Drug market?
3. What is the year over year growth of the global Neurodegenerative Disease Treatment Drug market?
4. What is the total value of the global Neurodegenerative Disease Treatment Drug market?
5. Who are the major players in the global Neurodegenerative Disease Treatment Drug market?
6. What are the growth factors driving the market demand?
This report studies the global Neurodegenerative Disease Treatment Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neurodegenerative Disease Treatment Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neurodegenerative Disease Treatment Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neurodegenerative Disease Treatment Drug total market, 2018-2029, (USD Million)
Global Neurodegenerative Disease Treatment Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Neurodegenerative Disease Treatment Drug total market, key domestic companies and share, (USD Million)
Global Neurodegenerative Disease Treatment Drug revenue by player and market share 2018-2023, (USD Million)
Global Neurodegenerative Disease Treatment Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Neurodegenerative Disease Treatment Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Neurodegenerative Disease Treatment Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbvie Inc., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International Gmbh, Hoffmann-La Roche and Merck & Co. Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neurodegenerative Disease Treatment Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Neurodegenerative Disease Treatment Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- N-methyl-D-aspartate Receptor antagonists
- Cholinesterase Inhibitors
- Dopamine Agonists
- Immunomodulatory Drugs
- Others
- Hospital
- Clinic
- Others
- Abbvie Inc.
- Amneal Pharmaceuticals Inc.
- Boehringer Ingelheim International Gmbh
- Hoffmann-La Roche
- Merck & Co. Inc.
1. How big is the global Neurodegenerative Disease Treatment Drug market?
2. What is the demand of the global Neurodegenerative Disease Treatment Drug market?
3. What is the year over year growth of the global Neurodegenerative Disease Treatment Drug market?
4. What is the total value of the global Neurodegenerative Disease Treatment Drug market?
5. Who are the major players in the global Neurodegenerative Disease Treatment Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Neurodegenerative Disease Treatment Drug Introduction
1.2 World Neurodegenerative Disease Treatment Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Neurodegenerative Disease Treatment Drug Total Market by Region (by Headquarter Location)
1.3.1 World Neurodegenerative Disease Treatment Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Neurodegenerative Disease Treatment Drug Market Size (2018-2029)
1.3.3 China Neurodegenerative Disease Treatment Drug Market Size (2018-2029)
1.3.4 Europe Neurodegenerative Disease Treatment Drug Market Size (2018-2029)
1.3.5 Japan Neurodegenerative Disease Treatment Drug Market Size (2018-2029)
1.3.6 South Korea Neurodegenerative Disease Treatment Drug Market Size (2018-2029)
1.3.7 ASEAN Neurodegenerative Disease Treatment Drug Market Size (2018-2029)
1.3.8 India Neurodegenerative Disease Treatment Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neurodegenerative Disease Treatment Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neurodegenerative Disease Treatment Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
2.2 World Neurodegenerative Disease Treatment Drug Consumption Value by Region
2.2.1 World Neurodegenerative Disease Treatment Drug Consumption Value by Region (2018-2023)
2.2.2 World Neurodegenerative Disease Treatment Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
2.4 China Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
2.5 Europe Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
2.6 Japan Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
2.7 South Korea Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
2.8 ASEAN Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
2.9 India Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
3 WORLD NEURODEGENERATIVE DISEASE TREATMENT DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Neurodegenerative Disease Treatment Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Neurodegenerative Disease Treatment Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Neurodegenerative Disease Treatment Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Neurodegenerative Disease Treatment Drug in 2022
3.3 Neurodegenerative Disease Treatment Drug Company Evaluation Quadrant
3.4 Neurodegenerative Disease Treatment Drug Market: Overall Company Footprint Analysis
3.4.1 Neurodegenerative Disease Treatment Drug Market: Region Footprint
3.4.2 Neurodegenerative Disease Treatment Drug Market: Company Product Type Footprint
3.4.3 Neurodegenerative Disease Treatment Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Neurodegenerative Disease Treatment Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Neurodegenerative Disease Treatment Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Neurodegenerative Disease Treatment Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Neurodegenerative Disease Treatment Drug Consumption Value Comparison
4.2.1 United States VS China: Neurodegenerative Disease Treatment Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Neurodegenerative Disease Treatment Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Neurodegenerative Disease Treatment Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Neurodegenerative Disease Treatment Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Neurodegenerative Disease Treatment Drug Revenue, (2018-2023)
4.4 China Based Companies Neurodegenerative Disease Treatment Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Neurodegenerative Disease Treatment Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Neurodegenerative Disease Treatment Drug Revenue, (2018-2023)
4.5 Rest of World Based Neurodegenerative Disease Treatment Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Neurodegenerative Disease Treatment Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Neurodegenerative Disease Treatment Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Neurodegenerative Disease Treatment Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 N-methyl-D-aspartate Receptor antagonists
5.2.2 Cholinesterase Inhibitors
5.2.3 Dopamine Agonists
5.2.4 Immunomodulatory Drugs
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Neurodegenerative Disease Treatment Drug Market Size by Type (2018-2023)
5.3.2 World Neurodegenerative Disease Treatment Drug Market Size by Type (2024-2029)
5.3.3 World Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Neurodegenerative Disease Treatment Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Neurodegenerative Disease Treatment Drug Market Size by Application (2018-2023)
6.3.2 World Neurodegenerative Disease Treatment Drug Market Size by Application (2024-2029)
6.3.3 World Neurodegenerative Disease Treatment Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Abbvie Inc.
7.1.1 Abbvie Inc. Details
7.1.2 Abbvie Inc. Major Business
7.1.3 Abbvie Inc. Neurodegenerative Disease Treatment Drug Product and Services
7.1.4 Abbvie Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Abbvie Inc. Recent Developments/Updates
7.1.6 Abbvie Inc. Competitive Strengths & Weaknesses
7.2 Amneal Pharmaceuticals Inc.
7.2.1 Amneal Pharmaceuticals Inc. Details
7.2.2 Amneal Pharmaceuticals Inc. Major Business
7.2.3 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Product and Services
7.2.4 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Amneal Pharmaceuticals Inc. Recent Developments/Updates
7.2.6 Amneal Pharmaceuticals Inc. Competitive Strengths & Weaknesses
7.3 Boehringer Ingelheim International Gmbh
7.3.1 Boehringer Ingelheim International Gmbh Details
7.3.2 Boehringer Ingelheim International Gmbh Major Business
7.3.3 Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Product and Services
7.3.4 Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Boehringer Ingelheim International Gmbh Recent Developments/Updates
7.3.6 Boehringer Ingelheim International Gmbh Competitive Strengths & Weaknesses
7.4 Hoffmann-La Roche
7.4.1 Hoffmann-La Roche Details
7.4.2 Hoffmann-La Roche Major Business
7.4.3 Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Product and Services
7.4.4 Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Hoffmann-La Roche Recent Developments/Updates
7.4.6 Hoffmann-La Roche Competitive Strengths & Weaknesses
7.5 Merck & Co. Inc.
7.5.1 Merck & Co. Inc. Details
7.5.2 Merck & Co. Inc. Major Business
7.5.3 Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Product and Services
7.5.4 Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Merck & Co. Inc. Recent Developments/Updates
7.5.6 Merck & Co. Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Neurodegenerative Disease Treatment Drug Industry Chain
8.2 Neurodegenerative Disease Treatment Drug Upstream Analysis
8.3 Neurodegenerative Disease Treatment Drug Midstream Analysis
8.4 Neurodegenerative Disease Treatment Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Neurodegenerative Disease Treatment Drug Introduction
1.2 World Neurodegenerative Disease Treatment Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Neurodegenerative Disease Treatment Drug Total Market by Region (by Headquarter Location)
1.3.1 World Neurodegenerative Disease Treatment Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Neurodegenerative Disease Treatment Drug Market Size (2018-2029)
1.3.3 China Neurodegenerative Disease Treatment Drug Market Size (2018-2029)
1.3.4 Europe Neurodegenerative Disease Treatment Drug Market Size (2018-2029)
1.3.5 Japan Neurodegenerative Disease Treatment Drug Market Size (2018-2029)
1.3.6 South Korea Neurodegenerative Disease Treatment Drug Market Size (2018-2029)
1.3.7 ASEAN Neurodegenerative Disease Treatment Drug Market Size (2018-2029)
1.3.8 India Neurodegenerative Disease Treatment Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neurodegenerative Disease Treatment Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Neurodegenerative Disease Treatment Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
2.2 World Neurodegenerative Disease Treatment Drug Consumption Value by Region
2.2.1 World Neurodegenerative Disease Treatment Drug Consumption Value by Region (2018-2023)
2.2.2 World Neurodegenerative Disease Treatment Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
2.4 China Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
2.5 Europe Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
2.6 Japan Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
2.7 South Korea Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
2.8 ASEAN Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
2.9 India Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029)
3 WORLD NEURODEGENERATIVE DISEASE TREATMENT DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Neurodegenerative Disease Treatment Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Neurodegenerative Disease Treatment Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Neurodegenerative Disease Treatment Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Neurodegenerative Disease Treatment Drug in 2022
3.3 Neurodegenerative Disease Treatment Drug Company Evaluation Quadrant
3.4 Neurodegenerative Disease Treatment Drug Market: Overall Company Footprint Analysis
3.4.1 Neurodegenerative Disease Treatment Drug Market: Region Footprint
3.4.2 Neurodegenerative Disease Treatment Drug Market: Company Product Type Footprint
3.4.3 Neurodegenerative Disease Treatment Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Neurodegenerative Disease Treatment Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Neurodegenerative Disease Treatment Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Neurodegenerative Disease Treatment Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Neurodegenerative Disease Treatment Drug Consumption Value Comparison
4.2.1 United States VS China: Neurodegenerative Disease Treatment Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Neurodegenerative Disease Treatment Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Neurodegenerative Disease Treatment Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Neurodegenerative Disease Treatment Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Neurodegenerative Disease Treatment Drug Revenue, (2018-2023)
4.4 China Based Companies Neurodegenerative Disease Treatment Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Neurodegenerative Disease Treatment Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Neurodegenerative Disease Treatment Drug Revenue, (2018-2023)
4.5 Rest of World Based Neurodegenerative Disease Treatment Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Neurodegenerative Disease Treatment Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Neurodegenerative Disease Treatment Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Neurodegenerative Disease Treatment Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 N-methyl-D-aspartate Receptor antagonists
5.2.2 Cholinesterase Inhibitors
5.2.3 Dopamine Agonists
5.2.4 Immunomodulatory Drugs
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Neurodegenerative Disease Treatment Drug Market Size by Type (2018-2023)
5.3.2 World Neurodegenerative Disease Treatment Drug Market Size by Type (2024-2029)
5.3.3 World Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Neurodegenerative Disease Treatment Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Neurodegenerative Disease Treatment Drug Market Size by Application (2018-2023)
6.3.2 World Neurodegenerative Disease Treatment Drug Market Size by Application (2024-2029)
6.3.3 World Neurodegenerative Disease Treatment Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Abbvie Inc.
7.1.1 Abbvie Inc. Details
7.1.2 Abbvie Inc. Major Business
7.1.3 Abbvie Inc. Neurodegenerative Disease Treatment Drug Product and Services
7.1.4 Abbvie Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Abbvie Inc. Recent Developments/Updates
7.1.6 Abbvie Inc. Competitive Strengths & Weaknesses
7.2 Amneal Pharmaceuticals Inc.
7.2.1 Amneal Pharmaceuticals Inc. Details
7.2.2 Amneal Pharmaceuticals Inc. Major Business
7.2.3 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Product and Services
7.2.4 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Amneal Pharmaceuticals Inc. Recent Developments/Updates
7.2.6 Amneal Pharmaceuticals Inc. Competitive Strengths & Weaknesses
7.3 Boehringer Ingelheim International Gmbh
7.3.1 Boehringer Ingelheim International Gmbh Details
7.3.2 Boehringer Ingelheim International Gmbh Major Business
7.3.3 Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Product and Services
7.3.4 Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Boehringer Ingelheim International Gmbh Recent Developments/Updates
7.3.6 Boehringer Ingelheim International Gmbh Competitive Strengths & Weaknesses
7.4 Hoffmann-La Roche
7.4.1 Hoffmann-La Roche Details
7.4.2 Hoffmann-La Roche Major Business
7.4.3 Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Product and Services
7.4.4 Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Hoffmann-La Roche Recent Developments/Updates
7.4.6 Hoffmann-La Roche Competitive Strengths & Weaknesses
7.5 Merck & Co. Inc.
7.5.1 Merck & Co. Inc. Details
7.5.2 Merck & Co. Inc. Major Business
7.5.3 Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Product and Services
7.5.4 Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Merck & Co. Inc. Recent Developments/Updates
7.5.6 Merck & Co. Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Neurodegenerative Disease Treatment Drug Industry Chain
8.2 Neurodegenerative Disease Treatment Drug Upstream Analysis
8.3 Neurodegenerative Disease Treatment Drug Midstream Analysis
8.4 Neurodegenerative Disease Treatment Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Neurodegenerative Disease Treatment Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Neurodegenerative Disease Treatment Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Neurodegenerative Disease Treatment Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Neurodegenerative Disease Treatment Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Neurodegenerative Disease Treatment Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Neurodegenerative Disease Treatment Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Neurodegenerative Disease Treatment Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Neurodegenerative Disease Treatment Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Neurodegenerative Disease Treatment Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Neurodegenerative Disease Treatment Drug Players in 2022
Table 12. World Neurodegenerative Disease Treatment Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Neurodegenerative Disease Treatment Drug Company Evaluation Quadrant
Table 14. Head Office of Key Neurodegenerative Disease Treatment Drug Player
Table 15. Neurodegenerative Disease Treatment Drug Market: Company Product Type Footprint
Table 16. Neurodegenerative Disease Treatment Drug Market: Company Product Application Footprint
Table 17. Neurodegenerative Disease Treatment Drug Mergers & Acquisitions Activity
Table 18. United States VS China Neurodegenerative Disease Treatment Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Neurodegenerative Disease Treatment Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Neurodegenerative Disease Treatment Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Neurodegenerative Disease Treatment Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Neurodegenerative Disease Treatment Drug Revenue Market Share (2018-2023)
Table 23. China Based Neurodegenerative Disease Treatment Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Neurodegenerative Disease Treatment Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Neurodegenerative Disease Treatment Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Neurodegenerative Disease Treatment Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Neurodegenerative Disease Treatment Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Neurodegenerative Disease Treatment Drug Revenue Market Share (2018-2023)
Table 29. World Neurodegenerative Disease Treatment Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Neurodegenerative Disease Treatment Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Neurodegenerative Disease Treatment Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Neurodegenerative Disease Treatment Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Neurodegenerative Disease Treatment Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Neurodegenerative Disease Treatment Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Abbvie Inc. Basic Information, Area Served and Competitors
Table 36. Abbvie Inc. Major Business
Table 37. Abbvie Inc. Neurodegenerative Disease Treatment Drug Product and Services
Table 38. Abbvie Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Abbvie Inc. Recent Developments/Updates
Table 40. Abbvie Inc. Competitive Strengths & Weaknesses
Table 41. Amneal Pharmaceuticals Inc. Basic Information, Area Served and Competitors
Table 42. Amneal Pharmaceuticals Inc. Major Business
Table 43. Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Product and Services
Table 44. Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Amneal Pharmaceuticals Inc. Recent Developments/Updates
Table 46. Amneal Pharmaceuticals Inc. Competitive Strengths & Weaknesses
Table 47. Boehringer Ingelheim International Gmbh Basic Information, Area Served and Competitors
Table 48. Boehringer Ingelheim International Gmbh Major Business
Table 49. Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Product and Services
Table 50. Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Boehringer Ingelheim International Gmbh Recent Developments/Updates
Table 52. Boehringer Ingelheim International Gmbh Competitive Strengths & Weaknesses
Table 53. Hoffmann-La Roche Basic Information, Area Served and Competitors
Table 54. Hoffmann-La Roche Major Business
Table 55. Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Product and Services
Table 56. Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Hoffmann-La Roche Recent Developments/Updates
Table 58. Merck & Co. Inc. Basic Information, Area Served and Competitors
Table 59. Merck & Co. Inc. Major Business
Table 60. Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Product and Services
Table 61. Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 62. Global Key Players of Neurodegenerative Disease Treatment Drug Upstream (Raw Materials)
Table 63. Neurodegenerative Disease Treatment Drug Typical Customers
Table 1. World Neurodegenerative Disease Treatment Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Neurodegenerative Disease Treatment Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Neurodegenerative Disease Treatment Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Neurodegenerative Disease Treatment Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Neurodegenerative Disease Treatment Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Neurodegenerative Disease Treatment Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Neurodegenerative Disease Treatment Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Neurodegenerative Disease Treatment Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Neurodegenerative Disease Treatment Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Neurodegenerative Disease Treatment Drug Players in 2022
Table 12. World Neurodegenerative Disease Treatment Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Neurodegenerative Disease Treatment Drug Company Evaluation Quadrant
Table 14. Head Office of Key Neurodegenerative Disease Treatment Drug Player
Table 15. Neurodegenerative Disease Treatment Drug Market: Company Product Type Footprint
Table 16. Neurodegenerative Disease Treatment Drug Market: Company Product Application Footprint
Table 17. Neurodegenerative Disease Treatment Drug Mergers & Acquisitions Activity
Table 18. United States VS China Neurodegenerative Disease Treatment Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Neurodegenerative Disease Treatment Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Neurodegenerative Disease Treatment Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Neurodegenerative Disease Treatment Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Neurodegenerative Disease Treatment Drug Revenue Market Share (2018-2023)
Table 23. China Based Neurodegenerative Disease Treatment Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Neurodegenerative Disease Treatment Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Neurodegenerative Disease Treatment Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Neurodegenerative Disease Treatment Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Neurodegenerative Disease Treatment Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Neurodegenerative Disease Treatment Drug Revenue Market Share (2018-2023)
Table 29. World Neurodegenerative Disease Treatment Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Neurodegenerative Disease Treatment Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Neurodegenerative Disease Treatment Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Neurodegenerative Disease Treatment Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Neurodegenerative Disease Treatment Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Neurodegenerative Disease Treatment Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Abbvie Inc. Basic Information, Area Served and Competitors
Table 36. Abbvie Inc. Major Business
Table 37. Abbvie Inc. Neurodegenerative Disease Treatment Drug Product and Services
Table 38. Abbvie Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Abbvie Inc. Recent Developments/Updates
Table 40. Abbvie Inc. Competitive Strengths & Weaknesses
Table 41. Amneal Pharmaceuticals Inc. Basic Information, Area Served and Competitors
Table 42. Amneal Pharmaceuticals Inc. Major Business
Table 43. Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Product and Services
Table 44. Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Amneal Pharmaceuticals Inc. Recent Developments/Updates
Table 46. Amneal Pharmaceuticals Inc. Competitive Strengths & Weaknesses
Table 47. Boehringer Ingelheim International Gmbh Basic Information, Area Served and Competitors
Table 48. Boehringer Ingelheim International Gmbh Major Business
Table 49. Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Product and Services
Table 50. Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Boehringer Ingelheim International Gmbh Recent Developments/Updates
Table 52. Boehringer Ingelheim International Gmbh Competitive Strengths & Weaknesses
Table 53. Hoffmann-La Roche Basic Information, Area Served and Competitors
Table 54. Hoffmann-La Roche Major Business
Table 55. Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Product and Services
Table 56. Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Hoffmann-La Roche Recent Developments/Updates
Table 58. Merck & Co. Inc. Basic Information, Area Served and Competitors
Table 59. Merck & Co. Inc. Major Business
Table 60. Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Product and Services
Table 61. Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 62. Global Key Players of Neurodegenerative Disease Treatment Drug Upstream (Raw Materials)
Table 63. Neurodegenerative Disease Treatment Drug Typical Customers
LIST OF FIGURES
Figure 1. Neurodegenerative Disease Treatment Drug Picture
Figure 2. World Neurodegenerative Disease Treatment Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Neurodegenerative Disease Treatment Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Neurodegenerative Disease Treatment Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Neurodegenerative Disease Treatment Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Neurodegenerative Disease Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Neurodegenerative Disease Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Neurodegenerative Disease Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Neurodegenerative Disease Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Neurodegenerative Disease Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Neurodegenerative Disease Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Neurodegenerative Disease Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 13. Neurodegenerative Disease Treatment Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Neurodegenerative Disease Treatment Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Neurodegenerative Disease Treatment Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Neurodegenerative Disease Treatment Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Neurodegenerative Disease Treatment Drug Markets in 2022
Figure 27. United States VS China: Neurodegenerative Disease Treatment Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Neurodegenerative Disease Treatment Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Neurodegenerative Disease Treatment Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Neurodegenerative Disease Treatment Drug Market Size Market Share by Type in 2022
Figure 31. N-methyl-D-aspartate Receptor antagonists
Figure 32. Cholinesterase Inhibitors
Figure 33. Dopamine Agonists
Figure 34. Immunomodulatory Drugs
Figure 35. Others
Figure 36. World Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2018-2029)
Figure 37. World Neurodegenerative Disease Treatment Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Neurodegenerative Disease Treatment Drug Market Size Market Share by Application in 2022
Figure 39. Hospital
Figure 40. Clinic
Figure 41. Others
Figure 42. Neurodegenerative Disease Treatment Drug Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Neurodegenerative Disease Treatment Drug Picture
Figure 2. World Neurodegenerative Disease Treatment Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Neurodegenerative Disease Treatment Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Neurodegenerative Disease Treatment Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Neurodegenerative Disease Treatment Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Neurodegenerative Disease Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Neurodegenerative Disease Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Neurodegenerative Disease Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Neurodegenerative Disease Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Neurodegenerative Disease Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Neurodegenerative Disease Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Neurodegenerative Disease Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 13. Neurodegenerative Disease Treatment Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Neurodegenerative Disease Treatment Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Neurodegenerative Disease Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Neurodegenerative Disease Treatment Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Neurodegenerative Disease Treatment Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Neurodegenerative Disease Treatment Drug Markets in 2022
Figure 27. United States VS China: Neurodegenerative Disease Treatment Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Neurodegenerative Disease Treatment Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Neurodegenerative Disease Treatment Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Neurodegenerative Disease Treatment Drug Market Size Market Share by Type in 2022
Figure 31. N-methyl-D-aspartate Receptor antagonists
Figure 32. Cholinesterase Inhibitors
Figure 33. Dopamine Agonists
Figure 34. Immunomodulatory Drugs
Figure 35. Others
Figure 36. World Neurodegenerative Disease Treatment Drug Market Size Market Share by Type (2018-2029)
Figure 37. World Neurodegenerative Disease Treatment Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Neurodegenerative Disease Treatment Drug Market Size Market Share by Application in 2022
Figure 39. Hospital
Figure 40. Clinic
Figure 41. Others
Figure 42. Neurodegenerative Disease Treatment Drug Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
